EXEL
Exelixis (EXEL)
$60
About Exelixis (EXEL)
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Details
Daily high
$41.77
Daily low
$40.83
Price at open
--
52 Week High
$49.62
52 Week Low
$31.90
Market cap
11.2B
Dividend yield
0.00%
Volume
1,529
Avg. volume
2.7M
P/E ratio
17.51
Exelixis News
Details
Daily high
$41.77
Daily low
$40.83
Price at open
--
52 Week High
$49.62
52 Week Low
$31.90
Market cap
11.2B
Dividend yield
0.00%
Volume
1,529
Avg. volume
2.7M
P/E ratio
17.51